Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Fibrin Fibrinogen Degradation Products  [Clear All Filters]
Journal Article
Papp AC, Hatzakis H, Bracey A, Wu KK. "ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies." Thromb Haemost. 1989;61(1):15-9.
Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. "Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study." Circulation. 1995;91(2):284-90.
Cushman M, O'Meara ES, Heckbert SR, Zakai NA, Rosamond WD. "Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology." Thromb Res. 2016;144:127-32.
Cushman M, Folsom AR, Wang L, et al. "Fibrin fragment D-dimer and the risk of future venous thrombosis." Blood. 2003;101(4):1243-8.
Weng L-C, Tang W, Rich SS, et al. "A genetic association study of D-dimer levels with 50K SNPs from a candidate gene chip in four ethnic groups." Thromb Res. 2014;134(2):462-7.
Gottesman RF, Cummiskey C, Chambless L, et al. "Hemostatic factors and subclinical brain infarction in a community-based sample: the ARIC study." Cerebrovasc Dis. 2009;28(6):589-94.
Lutsey PL, Folsom AR, Heckbert SR, Cushman M. "Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study." J Thromb Haemost. 2009;7(10):1639-48.
Folsom AR, Gottesman RF, Appiah D, Shahar E. "Plasma d-Dimer and Incident Ischemic Stroke and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study." Stroke. 2016;47(1):18-23.
Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK. "Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb Vasc Biol. 2001;21(4):611-7.
Folsom AR, Alonso A, George KM, Roetker NS, Tang W. "Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study." Thromb Res. 2015;136(4):781-5.
Shahar E, Folsom AR, Salomaa VV, et al. "Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators." Circulation. 1996;93(11):1970-5.
Thibord F, Song C, Pattee J, et al. FGL1 as a modulator of plasma D-dimer levels: Exome-wide marker analysis of plasma tPA, PAI-1, and D-dimer.. Vol. 19.; 2021. J Thromb Haemost 19(8).